No Data
HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $12 Price Target
H.C. Wainwright Maintains Dare Bioscience(DARE.US) With Buy Rating, Maintains Target Price $12
Daré Bioscience Awarded $10M From ARPA-H's Sprint For Women's Health To Advance DARE-HPV, Aimed At Transforming HPV-Related Cervical Disease Treatment; Funding To Support Development Over Two Years
Express News | Dare Bioscience - Lpc Agreed Not to Cause or Engage in Any Direct or Indirect Short Selling or Hedging of Co's Common Stock
Press Release: Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC
Express News | Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million With Lincoln Park Capital Fund, LLC
No Data
No Data